NVO: Novo-Nordisk A/S Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 311,752.04
Enterprise Value ($M) n/a
Book Value ($M) 76,680.00
Book Value / Share 33.96
Price / Book n/a
NCAV ($M) -46,674.00
NCAV / Share -20.67
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.51
Return on Assets (ROA) 0.27
Return on Equity (ROE) 0.75

Liquidity (mrq)
Quick Ratio 0.74
Current Ratio 0.92

Balance Sheet (mrq) ($M)
Current Assets 119,482.00
Assets 242,836.00
Liabilities 166,156.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-01 13G/A BlackRock Inc. 7.00 7.16

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-01-27 152,700 1,050,922 14.53
2023-01-26 130,158 1,256,137 10.36
2023-01-25 198,222 1,530,643 12.95
2023-01-24 158,414 1,890,766 8.38
2023-01-23 155,416 1,235,407 12.58

(click for more detail)

Similar Companies
MRK – Merck & Co., Inc. MYOV – Myovant Sciences Ltd.
NUVB – Nuvation Bio Inc NVS – Novartis AG
OGN – Organon & Co.


Financial data and stock pages provided by
Fintel.io